SEC Form D · filed April 14, 2023
Checkpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
James F. Oliviero, Iii · Waltham, MAExec · DirectorLindsay A. Rosenwald · Waltham, MADirectorBarry F. Salzman · Waltham, MADirectorGarrett F. Gray · Waltham, MAExecScott A. Boilen · Waltham, MADirectorNeil F. Herskowitz · Waltham, MADirectorChristian F. Bechon · Waltham, MADirectorMichael F. Weiss · Waltham, MADirectorManuel E. Tarrasa Sanchez · Madrid, U3DirectorToyin Ajayi · Dover, DEDirectorJose M. Moran Adarraga · Madrid, U3DirectorAshley Mayer · Dover, DEDirectorAlex Koglin · Santa Fe, NMDirectorBarbara Serrano Sanchez · Madrid, U3DirectorStuart Orgill · San Francisco, CAExecMarco M. Buhigas Moran · Madrid, U3Exec · DirectorDavid Carew · Toronto, Ontario, CanadaExec · DirectorMaxim D. Crewe · London, United KingdomExecThomas P. Railhac · London, United KingdomDirectorSven Gosta P. Pattersson · London, United KingdomDirectorSimon B. Creswell · St Peter Port, Y7DirectorHiroaki Kobayashi · BALTIMORE, MDDirectorJeffrey Cleland · BALTIMORE, MDDirectorAkihiro Ko · BALTIMORE, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗